enfr

SCN’s vision is to capitalize upon Canada’s competitive advantage in stem cells for the benefit of Canadians.

Supporting and building Canada’s stem cell and regenerative medicine research sector has been the raison d’être of the Stem Cell Network (SCN) since its inception in 2001. Its work has been supported by the Government of Canada from the beginning.

In just over 17 years, SCN has forged a national community that has transformed stem cell research in Canada, brought research to the point where regenerative medicine is changing clinical practice, and established an outstanding international reputation. SCN has pushed the boundaries of what was a basic research area towards translational outcomes for the clinic and marketplace. SCN has invested $100M in innovative translational research, training and outreach. This strategic funding has benefitted approximately 170 world-class research groups and 2,500 trainees from across Canada.  SCN has also catalyzed 18 clinical trials and 17 startup biotechnology companies. Its investigators have leveraged upwards of $100M in partner contributions while SCN has incubated several international and Canadian research networks and organizations.

2,500

Trainees

170

Research Groups

$100M

In Research, Training and Outreach

$100M

In Partner Support

This is our science. It's Canada's time.

Show your support for stem cell research in Canada by signing our petition. 

In the news

Canada’s Women in Regenerative Medicine initiative launched in Ottawa

It’s been well documented that women occupy fewer leadership roles and get less recognition than their male counterparts across nearly all professional sectors, including the sciences. It’s been suggested that one way to bridge this gap is to facilitate greater networking and opportunities for mentorship. In the spirit of this aim, on November 12, the …

Read more